The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-benzyl-3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1H-pyrazol-4-yl)imidazolidine-2,4,5-trione ID: ALA4471870
PubChem CID: 57944981
Max Phase: Preclinical
Molecular Formula: C19H17N5O4
Molecular Weight: 379.38
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1noc(C)c1Cn1cc(N2C(=O)C(=O)N(Cc3ccccc3)C2=O)cn1
Standard InChI: InChI=1S/C19H17N5O4/c1-12-16(13(2)28-21-12)11-22-10-15(8-20-22)24-18(26)17(25)23(19(24)27)9-14-6-4-3-5-7-14/h3-8,10H,9,11H2,1-2H3
Standard InChI Key: AHTLZRURDSTFOP-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
23.6779 -4.2882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4992 -4.2882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7536 -3.5074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0906 -3.0211 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.4277 -3.5074 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.1967 -4.9487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5352 -3.2518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9829 -4.9499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7998 -4.8654 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.3450 -5.4774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0961 -5.1459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0116 -4.3289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2084 -4.1541 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.8075 -5.5554 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.8897 -6.3694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6927 -6.5389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1022 -5.8275 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.5521 -5.2184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7190 -4.4185 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.9148 -5.7409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3960 -6.4014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0627 -7.1486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5433 -7.8086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3568 -7.7224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6874 -6.9704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2048 -6.3136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2816 -6.9153 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.0261 -7.2850 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 1 0
1 6 1 0
3 7 1 0
2 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 9 1 0
11 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 14 1 0
18 19 2 0
17 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
15 27 2 0
16 28 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.38Molecular Weight (Monoisotopic): 379.1281AlogP: 2.03#Rotatable Bonds: 5Polar Surface Area: 101.54Molecular Species: NEUTRALHBA: 7HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.67CX LogP: 1.47CX LogD: 1.47Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.50Np Likeness Score: -2.00
References 1. Fotsing JR, Darmohusodo V, Patron AP, Ching BW, Brady T, Arellano M, Chen Q, Davis TJ, Liu H, Servant G, Zhang L, Williams M, Saganich M, Ditschun T, Tachdjian C, Karanewsky DS.. (2020) Discovery and Development of S6821 and S7958 as Potent TAS2R8 Antagonists., 63 (9): [PMID:32330040 ] [10.1021/acs.jmedchem.0c00388 ]